Analysis of Tumor Glycosylation Characteristics and Implications for Immune Checkpoint Inhibitor’s Efficacy for Breast Cancer
Wenchang Lv(Tongji Hospital), Qi Zhang(Second Affiliated Hospital of Zhejiang University), Yufang Tan(Tongji Hospital), Jun Zhang(Wuhan University), Han Mei(China Three Gorges University), Min Wu(Soochow University), Honghao Yu(Guilin Medical University), Yiping Wu(Tongji Hospital)
Cited by 16
Related Papers
HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib
|Annals of Oncology|2018|217
Early detection of lung cancer by using an autoantibody panel in Chinese population
|OncoImmunology|2017|203
Hypoxia-inducible factor-2α promotes tumor progression and has crosstalk with Wnt/β-catenin signaling in pancreatic cancer
|Molecular Cancer|2017|124
Consensus for HER2 alterations testing in non-small-cell lung cancer
|ESMO Open|2022|110